Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: Dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics

Michael Millward

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: Dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics

Internal Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	PMID 12419756
Pages (from-to)	1810-1818
Journal	Annals of Oncology
Volume	13
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{00e2db498c01446d8cba97d3422ede3a,

title = "Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: Dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics",

author = "Michael Millward",

year = "2002",

language = "English",

volume = "13",

pages = "1810--1818",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: Dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics. / Millward, Michael.
In: Annals of Oncology, Vol. 13, PMID 12419756, 2002, p. 1810-1818.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: Dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics

AU - Millward, Michael

PY - 2002

Y1 - 2002

M3 - Article

SN - 0923-7534

VL - 13

SP - 1810

EP - 1818

JO - Annals of Oncology

JF - Annals of Oncology

M1 - PMID 12419756

ER -